Literature DB >> 31339059

Artificial Pancreas: Evaluating the ARG Algorithm Without Meal Announcement.

Emilia Fushimi1,2, Patricio Colmegna2,3,4, Hernán De Battista1,2, Fabricio Garelli1,2, Ricardo Sánchez-Peña2,4.   

Abstract

BACKGROUND: Either under standard basal-bolus treatment or hybrid closed-loop control, subjects with type 1 diabetes are required to count carbohydrates (CHOs). However, CHO counting is not only burdensome but also prone to errors. Recently, an artificial pancreas algorithm that does not require premeal insulin boluses-the so-called automatic regulation of glucose (ARG)-was introduced. In its first pilot clinical study, although the exact CHO counting was not required, subjects still needed to announce the meal time and classify the meal size.
METHOD: An automatic switching signal generator (SSG) is proposed in this work to remove the manual mealtime announcement from the control strategy. The SSG is based on a Kalman filter and works with continuous glucose monitoring readings only.
RESULTS: The ARG algorithm with unannounced meals (ARGum) was tested in silico under the effect of different types of mixed meals and intrapatient variability, and contrasted with the ARG algorithm with announced meals (ARGam). Simulations reveal that, for slow-absorbing meals, the time in the euglycemic range, [70-180] mg/dL, increases using the unannounced strategy (ARGam: 78.1 [68.6-80.2]% (median [IQR]) and ARGum: 87.8 [84.5-90.6]%), while similar results were found with fast-absorbing meals (ARGam: 87.4 [86.0-88.9]% and ARGum: 87.6 [86.1-88.8]%). On the other hand, when intrapatient variability is considered, time in euglycemia is also comparable (ARGam: 81.4 [75.4-83.5]% and ARGum: 80.9 [77.0-85.1]%).
CONCLUSION: In silico results indicate that it is feasible to perform an in vivo evaluation of the ARG algorithm with unannounced meals.

Entities:  

Keywords:  artificial pancreas; carbohydrate counting; sliding mode control; switched control

Year:  2019        PMID: 31339059      PMCID: PMC6835180          DOI: 10.1177/1932296819864585

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  29 in total

1.  Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp.

Authors:  Trang T Ly; Anirban Roy; Benyamin Grosman; John Shin; Alex Campbell; Salman Monirabbasi; Bradley Liang; Rie von Eyben; Satya Shanmugham; Paula Clinton; Bruce A Buckingham
Journal:  Diabetes Care       Date:  2015-06-06       Impact factor: 19.112

2.  Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.

Authors:  Gregory P Forlenza; Sunil Deshpande; Trang T Ly; Daniel P Howsmon; Faye Cameron; Nihat Baysal; Eric Mauritzen; Tatiana Marcal; Lindsey Towers; B Wayne Bequette; Lauren M Huyett; Jordan E Pinsker; Ravi Gondhalekar; Francis J Doyle; David M Maahs; Bruce A Buckingham; Eyal Dassau
Journal:  Diabetes Care       Date:  2017-06-05       Impact factor: 19.112

3.  Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.

Authors:  V Gingras; R Rabasa-Lhoret; V Messier; M Ladouceur; L Legault; A Haidar
Journal:  Diabetes Metab       Date:  2015-06-10       Impact factor: 6.041

4.  Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.

Authors:  Alexander Abitbol; Remi Rabasa-Lhoret; Virginie Messier; Laurent Legault; Mohamad Smaoui; Nathan Cohen; Ahmad Haidar
Journal:  Diabetes Technol Ther       Date:  2018-02-02       Impact factor: 6.118

5.  Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties.

Authors:  Dawei Shi; Eyal Dassau; Francis J Doyle
Journal:  IEEE Trans Biomed Eng       Date:  2018-08-21       Impact factor: 4.538

6.  One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator.

Authors:  Roberto Visentin; Chiara Dalla Man; Claudio Cobelli
Journal:  IEEE Trans Biomed Eng       Date:  2016-02-26       Impact factor: 4.538

7.  The UVA/PADOVA Type 1 Diabetes Simulator: New Features.

Authors:  Chiara Dalla Man; Francesco Micheletto; Dayu Lv; Marc Breton; Boris Kovatchev; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

8.  Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.

Authors:  B Wayne Bequette
Journal:  Annu Rev Control       Date:  2012-12       Impact factor: 6.091

9.  Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.

Authors:  Ricardo Sánchez-Peña; Patricio Colmegna; Fabricio Garelli; Hernán De Battista; Demián García-Violini; Marcela Moscoso-Vásquez; Nicolás Rosales; Emilia Fushimi; Enrique Campos-Náñez; Marc Breton; Valeria Beruto; Paula Scibona; Cintia Rodriguez; Javier Giunta; Ventura Simonovich; Waldo H Belloso; Daniel Cherñavvsky; Luis Grosembacher
Journal:  J Diabetes Sci Technol       Date:  2018-07-12

10.  Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care.

Authors:  Lia Bally; Hood Thabit; Sara Hartnell; Eveline Andereggen; Yue Ruan; Malgorzata E Wilinska; Mark L Evans; Maria M Wertli; Anthony P Coll; Christoph Stettler; Roman Hovorka
Journal:  N Engl J Med       Date:  2018-06-25       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.